Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Cai Cun Zhou"'
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 10, Pp 1135-1137 (2021)
Externí odkaz:
https://doaj.org/article/d49692367edd41d287ba407a21509761
Autor:
An-Wen Xiong, Jue-Min Fang, Sheng-Xiang Ren, Wei Li, Jing Wang, Yu Zhao, Guo-You Chen, Qing Xu, Cai-Cun Zhou
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionThe therapeutic cancer vaccine recombinant Epidermal Growth Factor (EGF)-CRM197 is a novel combined conjugate EGF with CRM197 as a carrier protein. Immunization with the EGF-CRM197 vaccine can induce high levels of neutralizing anti-EGF a
Externí odkaz:
https://doaj.org/article/be846440cbd8444a941e546a2d628629
Autor:
Su-Gang Gong, Lan Wang, Bigyan Pudasaini, Ping Yuan, Rong Jiang, Qin-Hua Zhao, Jing He, Rui Zhang, Wen-hui Wu, Jin-Ming Liu, Cai-cun Zhou
Publikováno v:
Canadian Respiratory Journal, Vol 2018 (2018)
Background and objective: Two endothelin receptor antagonists (ETRAs), bosentan and ambrisentan, are approved for patients with pulmonary arterial hypertension (PAH). However, there is little information about the transition strategy between these tw
Externí odkaz:
https://doaj.org/article/0eda9ccd99524a759332c7cdf4eaee33
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e103431 (2014)
To determine the role of brain metastases (BM) and overall survival (OS) in patients with non-small cell lung cancer (NSCLC) by performing a meta-analysis of the RCTs (randomized controlled clinical trials) and non-RCTs (non-randomized controlled cli
Externí odkaz:
https://doaj.org/article/00d469665d424e38bd70749703b837c8
Autor:
Xiaoxia Chen, Nong Yang, Yongchang Zhang, Tao Jiang, Xuefei Li, Chao Zhao, Shengxiang Ren, Chunxia Su, Cai-cun Zhou
Publikováno v:
European journal of cancer (Oxford, England : 1990). 121
Previous studies suggested that epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKIs) plus bevacizumab could significantly prolong progression-free survival (PFS) than EGFR-TKI alone as first-line setting for patients with EGFR-mut
Publikováno v:
Oncology Letters
The present study aimed to explore the role of integrin β1 and the relevant signaling pathways in acquired gefitinib resistance in non-small cell lung cancer (NSCLC). The inhibitory effects of gefitinib, with or without LY294002, on cellular prolife
Autor:
Bao Hui Han, Yunpeng Liu, Jian Ping Xiong, Peng Hui Zhou, Yong Song, Xiaolong Fu, Wei Min Mao, Yuan Chen, Jizhen Lin, Gang Wu, Lin Wu, Jian Hua Chang, Wen-Zhao Zhong, Yun Fan, Jie Wang, Chun Chen, Jun Liang, Chang Li Wang, Wen Fan, Hao Sun, Shun Lu, Cheng Huang, Zhe Liu, Sheng Lin Ma, Jian Jun Wang, Gui Bin Qiao, Nong Yang, Qing Zhou, Yong He, Cai Cun Zhou, Cheng Ping Hu, He Long Zhang, Ji Feng Feng, Mei Lin Liao, Bo Zhu, Qun Wang, Qiong Zhao, X. Zhang, Qi Bin Song, Jie Hu, Zhong Zhen Guan, Chen Yan Gao, Yi-Long Wu, X.-N. Yang, Jin Ji Yang, Yue Yin Pan, Fan Yang, Ming Fang Zhao, Ying Cheng, Xiaoqing Liu, Jun Zhao, Yi Hu, Yan Fang Guan, Nan Wu, Ke-Neng Chen, Zhi Yong Ma
Publikováno v:
Translational lung cancer research. 7(3)
The notable clinical success of cancer immunotherapy using checkpoint blockade suggests that it is likely to form the foundation of curative therapy for many malignancies. However, checkpoint blockades do not achieve sustained clinical response in mo
Autor:
Wen-Hui Wu, Qin-Hua Zhao, Jing He, Cai-cun Zhou, Rong Jiang, Su-Gang Gong, Rui Zhang, Ping Yuan, Lan Wang, Jinming Liu, Bigyan Pudasaini
Publikováno v:
Canadian Respiratory Journal
Canadian Respiratory Journal, Vol 2018 (2018)
Canadian Respiratory Journal, Vol 2018 (2018)
Background and objective: Two endothelin receptor antagonists (ETRAs), bosentan and ambrisentan, are approved for patients with pulmonary arterial hypertension (PAH). However, there is little information about the transition strategy between these tw
Publikováno v:
Oncology Letters
Mosquito coils, which are commonly used as residential insecticides in Asia, contain different concentrations of octachlorodipropyl ether (S-2) as a synergist or an active ingredient. As bis(chloromethyl) ether (BCME) is an extremely potent lung carc
Autor:
Hai Ying Wu, Shi Ying Yu, Chang Ping Wu, Xiao A. Hu, He Huang, Ying Liang, Cai Cun Zhou, Jian Ping Xiong, Qing Xiang Shao, Zhong Zhen Guan, Shunchang Jiao, Yang Zhang, Xu Qing Yang, Ke Jun Liu, Jie Wang, Yun Zhong Zhu, Shaobin Wang, Jin Peng, Yu Xian Bai, Shi Xiu Wu, Mengzhao Wang, Ji Feng
Publikováno v:
Archives of Medical Science : AMS
Introduction The aim of this study was to compare the efficacy and toxicity of dicycloplatin plus paclitaxel with those of carboplatin plus paclitaxel as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC). Material and